Patent details

EP1333832 Title: NOVEL USES OF COMBINED 5-HT1A AGONISTS AND SEROTONIN REUPTAKE INHIBITORS

Basic Information

Publication number:
EP1333832
PCT Application Number:
PCT/EP/2001/011952
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019835552
PCT Publication Number:
WO/2002/040024
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL USES OF COMBINED 5-HT1A AGONISTS AND SEROTONIN REUPTAKE INHIBITORS
French Title of Invention:
UTILISATIONS NOUVELLES D'AGONISTES 5-HT1A ET D'INHIBITEURS DE RECAPTAGE DE SEROTININE COMBINES
German Title of Invention:
NEUE VERWENDUNG VON SUBSTANZEN MIT KOMBINIERTEN 5-HT1A AGONISTISCHEN UND SEROTONIN REUPTAKE INHIBITOR-AKTIVITÄTEN
SPC Number:

Dates

Filing date:
16/10/2001
Grant date:
28/11/2007
EP Publication Date:
28/11/2007
PCT Publication Date:
23/05/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/08/2003
EP B1 Publication Date:
28/11/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/10/2008
Expiration date:
16/10/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/10/2001
 
 

Name:
Merck Patent GmbH
Address:
Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Inventor

Name:
BARTOSZYK Gerd
Address:
Germany (DE)

Priority

Priority Number:
00124815
Priority Date:
14/11/2000
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/495;
Filing date Document type Number of pages